NCT03563170 QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine Status WITHDRAWN Phase PHASE1/PHASE2
NCT03556358 Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer Status COMPLETED Phase PHASE3
NCT03555851 Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy Status RECRUITING Phase N/A
NCT03554109 QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine Status WITHDRAWN Phase PHASE2
NCT03553537 Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma Status UNKNOWN Phase PHASE3
NCT03553238 Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL Status UNKNOWN Phase PHASE2/PHASE3
NCT03536039 RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis Factor Status COMPLETED Phase PHASE2
NCT03531736 T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic Anemia Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03531281 Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant Status WITHDRAWN Phase PHASE1
NCT03530462 To Explore Cognitive Neural Mechanism of Autoimmune Encephalitis by Using Neuropsychological Tests and Multi-modal MRI Status COMPLETED Phase N/A
NCT03528421 Assessment of Safety and Efficacy of IM19 for Relapsed or Refractory NHL Patients Status UNKNOWN Phase PHASE1
NCT03520647 Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis Status RECRUITING Phase PHASE2
NCT03518242 Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer Status COMPLETED Phase PHASE1
NCT03518112 Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia Status TERMINATED Phase PHASE2
NCT03517137 Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03514836 A Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic Castration-resistant Prostate Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT03505762 Tailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment Status ACTIVE_NOT_RECRUITING Phase PHASE2